Medication Management at ADHD Philadelphia

Medication management is one component of a comprehensive ADHD treatment plan.

For adults in Pennsylvania and Delaware, we provide:

• Evidence-based stimulant prescribing when clinically appropriate
• Non-stimulant medication options
• Structured 30-day follow-up monitoring
• Executive function support integration
• Ongoing reassessment of treatment effectiveness

Our goal is not just symptom reduction — but safe, sustainable, and responsible long-term care.

Stimulant Treatment Policy & Monitoring Standards

🏛 Stimulant Treatment Policy & Monitoring Standards

Safe, Structured ADHD Care in Pennsylvania and Delaware

At ADHD Philadelphia, we provide evidence-based treatment for adults with Attention-Deficit/Hyperactivity Disorder (ADHD).

Stimulant medications can be highly effective when prescribed appropriately. They can improve focus, task initiation, and overall executive functioning. However, because these medications are federally regulated controlled substances, they require thoughtful monitoring and responsible medical oversight.

Our goal is simple:
Provide effective treatment while prioritizing long-term safety, compliance, and clinical integrity.

Below is an overview of how stimulant treatment is managed in our practice.

Why Stimulant Medications Require Monitoring

Medications such as Adderall (amphetamine salts), Vyvanse (lisdexamfetamine), and methylphenidate-based treatments are classified as Schedule II controlled substances under federal law.

This classification exists because these medications:

  • Have clear medical benefit when properly prescribed

  • Carry potential for misuse or diversion

  • Require ongoing medical oversight

  • Must be prescribed in compliance with Pennsylvania and Delaware regulations

Monitoring is not about mistrust.
It is about safety, compliance, and responsible prescribing.

Our 30-Day Monitoring Model

All stimulant treatment at ADHD Philadelphia is evaluated on a structured 30-day basis.

This typically includes:

  • Prescriptions written in 30-day supplies

  • Regular review of symptom response

  • Assessment of side effects

  • Ongoing evaluation of medical necessity

  • Treatment adjustments when clinically indicated

This model ensures that medication remains effective, appropriate, and aligned with your treatment goals.

Prescription Drug Monitoring Program (PDMP) Review

Before issuing any stimulant prescription, we check the Prescription Drug Monitoring Program (PDMP) every time.

The PDMP is a state-regulated database used across Pennsylvania and Delaware to:

  • Promote patient safety

  • Prevent medication duplication

  • Identify potential drug interactions

  • Reduce misuse and diversion

PDMP review is a standard part of responsible stimulant prescribing in our practice.

Cardiovascular Safety & Possible EKG Requirements

Stimulants may increase heart rate and blood pressure.

Depending on your medical history, you may be asked to:

  • Obtain an EKG prior to starting medication

  • Provide clearance from a primary care provider or cardiologist

  • Monitor blood pressure regularly

  • Participate in follow-up cardiovascular assessments

Your safety always comes first.

Urine Drug Screening & Follow-Up Appointments

Because stimulant medications are controlled substances, periodic monitoring may include:

  • Urine drug screening

  • Structured follow-up visits

  • Occasional in-person appointments when clinically indicated

Monitoring requirements are individualized, but participation in follow-up care is part of responsible treatment.

Substance Use Policy

Stimulant prescribing in our practice requires abstinence from non-prescribed substances.

This includes:

  • Cannabis, marijuana, THC products (including medical marijuana)

  • Illicit substances

  • Misuse of alcohol

  • Unauthorized prescription medications

This policy exists to:

  • Reduce cardiovascular risk

  • Reduce psychiatric risk

  • Minimize medication interaction complications

  • Maintain compliance with professional prescribing standards

If substance use concerns arise, stimulant treatment may be paused or discontinued.

We understand this policy may not be the right fit for everyone — and we are transparent about that from the start.

Who We May Not Be the Best Fit For

We may not be the best clinical match for individuals who:

  • Prefer minimal monitoring

  • Are unwilling to participate in follow-up requirements

  • Wish to combine stimulant treatment with cannabis use

  • Seek early refills or non-structured prescribing

We specialize in structured, safety-focused ADHD care.

Alternatives to Stimulant Medication

Stimulants are not the only treatment option for ADHD.

We also discuss:

  • Non-stimulant medications

  • Executive functioning support strategies

  • ADHD-focused cognitive behavioral therapy

  • Behavioral structure systems

  • Sleep, exercise, and lifestyle optimization

Treatment plans are individualized based on your goals and medical history.

Our Commitment to Responsible ADHD Care in PA & DE

We are committed to:

  • Ethical prescribing

  • Evidence-based treatment

  • Transparent policies

  • Regulatory compliance

  • Long-term patient safety

Our goal is not just symptom improvement —
but sustainable, medically responsible ADHD management.

Ready to Begin?

If you are an adult located in Pennsylvania or Delaware seeking structured ADHD evaluation and treatment, we invite you to schedule an appointment.

👉 Book Your ADHD Evaluation Today

Telehealth appointments are available throughout PA and DE.
In-person appointments may be scheduled after the initial telehealth visit.